Cancer Clinical Trial
Evaluating the Impact of the McMaster Optimal Aging Portal on Knowledge, Behavioural Intentions and Health Behaviours Related to Cancer Risk in Underserved Populations.
|Contact||Sarah Neil-Sztramko, PhD|
|Status||Not yet recruiting|
|Start date||August 1, 2017|
|Completion date||March 31, 2018|
The goal of the McMaster Optimal Aging Portal is to be a trustworthy source for health information. The Portal team can see (through measuring analytics of website use) that thousands of people are using the Portal and the knowledge-sharing strategies in place (email alerts, Twitter and Facebook), with many more users added each month. Previous studies have measured the quality and trustworthiness of health information available online; others have studied the numbers and populations who use different types of information and how easy it is to use and understand. This study builds on that knowledge to find out: if easy-to-understand evidence-based messages reach members of the public, do these messages change what people know and think to do to stay healthy (in this case, what they know and think to do to lower their risk of cancer)?
Half of cancers are preventable through lifestyle modification such as smoking cessation,
healthy eating, increasing physical activity and reducing alcohol intake; however, few
Canadians engage in behaviours that are in line with cancer prevention guidelines. This may
be in part due to lack of access to evidence-based information and the mixed messages on
effective cancer prevention strategies that are propagated in the popular media.
The McMaster Optimal Aging Portal (the Portal) is a knowledge translation (KT) tool launched in 2014 to increase public access to trustworthy health information. Citizen-friendly content (blog posts, evidence summaries, web resource ratings) provide easy-to-read 'bottom line' messages appropriate for all audiences. Investigators would now like to know if and how KT strategies used to disseminate citizen-targeted information on cancer prevention impact knowledge, behavioural intentions and health behaviours of Canadian adults.
This study will use a sequential mixed-methods design consisting of a two-arm randomized controlled trial (RCT) and a qualitative process study to explore RCT findings in depth. This formative approach will allow for a deeper analysis of the outcomes of interest (knowledge, intentions and behaviours), and the KT process. Following baseline data collection, eligible participants will be randomized to a 12-week intervention or control group.
During the intervention, participants will have access to the Portal, be invited to follow a Twitter and Facebook feed, and receive tailored weekly email alerts including blog posts and evidence summaries on cancer prevention. Control group participants will have access the Portal in a 'self-serve' fashion, but will not receive KT strategies.
|Recruiting||NCT01285037 - A Study of LY2801653 in Advanced Cancer||Phase 1|
|Active, not recruiting||NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone||Phase 2|
|Completed||NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development||N/A|
|Terminated||NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer||Phase 1|
|Completed||NCT01077414 - Phenomenological Study of Psycho-Socio-Spiritual Healing in the Context of Chronic or Life-Threatening Illness||N/A|
|Active, not recruiting||NCT00587886 - Estrogen, Diet, Genetics and Endometrial Cancer||N/A|
|Enrolling by invitation||NCT02565004 - Clinical and Laboratory Analysis of Familial Cancer||N/A|
|Recruiting||NCT02839889 - Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)||Phase 4|
|Recruiting||NCT02891993 - Pilot Study of a Symptom Monitoring Intervention for Hospitalized Patients With Cancer||N/A|
|Recruiting||NCT02921919 - Open-Label Extension and Safety Study of Talazoparib||Phase 2|
|Recruiting||NCT02869802 - Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis||N/A|
|Not yet recruiting||NCT02883699 - Individually Tailored Training Prescriptions in Cancer Patients: The TOP Study||N/A|
|Recruiting||NCT02550925 - Acceptance and Commitment Therapy (ACT) for Anxious Cancer Survivors||N/A|
|Recruiting||NCT02502396 - Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center||N/A|
|Recruiting||NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy||N/A|
|Recruiting||NCT02662621 - Pilot Study With the Aim to Quantify a Stress Protein in the Blood and in the Urine for the Monitoring and Early Diagnosis of Malignant Solid Tumors||N/A|
|Recruiting||NCT02552953 - A Pharmacologic Study of CYC065, a Cyclin Dependent Kinase Inhibitor, in Patients With Advanced Cancers||Phase 1|
|Recruiting||NCT02528357 - GSK3174998 Alone or With Pembrolizumab in Subjects With Advanced Solid Tumors (ENGAGE-1)||Phase 1|
|Recruiting||NCT02765451 - Study Evaluating Intervention in the Development of Clinical Research in Non-Academic Health Institution (ERNU)||N/A|
|Recruiting||NCT02483247 - A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer||Phase 1/Phase 2|